A Limited But Necessary Indication of Stem Cell Transplantation for Chronic Myelogeneous Leukemia in the Era of Tyrosine Kinase Inhibitors

被引：0

作者：

Imataki, Osamu ^{[1
]}

机构：

[1] Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol, Miki, Kagawa 7610793, Japan

来源：

TRANSPLANTATION | 2014年 / 97卷 / 01期

关键词：

CHRONIC MYELOID-LEUKEMIA; CHRONIC PHASE; IMATINIB; THERAPY; ABNORMALITIES; MONOSOMY-7;

D O I：

10.1097/01.TP.0000437675.24458.25

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E4 / E5

页数：2

共 11 条

[1]

[Anonymous], 2008, WHO CLASS TUM HAEM L, V2, P40

[2] The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells [J].

Deininger, Michael W. N. ;

Cortes, Jorge ;

Paquette, Ron ;

Park, Byung ;

Hochhaus, Andreas ;

Baccarani, Michele ;

Stone, Richard ;

Fischer, Thomas ;

Kantarjian, Hagop ;

Niederwieser, Dietger ;

Gambacorti-Passerini, Carlo ;

So, Charlene ;

Gathmann, Insa ;

Goldman, John M. ;

Smith, Douglas ;

Druker, Brian J. ;

Guilhot, Francois .

CANCER, 2007, 110 (07) :1509-1519

[3] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].

Druker, Brian J. ;

Guilhot, Francois ;

O'Brien, Stephen G. ;

Gathmann, Insa ;

Kantarjian, Hagop ;

Gattermann, Norbert ;

Deininger, Michael W. N. ;

Silver, Richard T. ;

Goldman, John M. ;

Stone, Richard M. ;

Cervantes, Francisco ;

Hochhaus, Andreas ;

Powell, Bayard L. ;

Gabrilove, Janice L. ;

Rousselot, Philippe ;

Reiffers, Josy ;

Cornelissen, Jan J. ;

Hughes, Timothy ;

Agis, Hermine ;

Fischer, Thomas ;

Verhoef, Gregor ;

Shepherd, John ;

Saglio, Giuseppe ;

Gratwohl, Alois ;

Nielsen, Johan L. ;

Radich, Jerald P. ;

Simonsson, Bengt ;

Taylor, Kerry ;

Baccarani, Michele ;

So, Charlene ;

Letvak, Laurie ;

Larson, Richard A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417

[4] Factors influencing a second myeloid malignancy in patients with Philadelphia-negative-7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia [J].

Groves, Michael J. ;

Sales, Mark ;

Baker, Lee ;

Griffiths, Michael ;

Pratt, Norman ;

Tauro, Sudhir .

CANCER GENETICS, 2011, 204 (01) :39-44

[5] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase [J].

Jabbour, Elias ;

Kantarjian, Hagop M. ;

Abruzzo, Lynne V. ;

O'Brien, Susan ;

Garcia-Manero, Guillermo ;

Verstovsek, Srdan ;

Shan, Jianqin ;

Rios, Mary Beth ;

Cortes, Jorge .

BLOOD, 2007, 110 (08) :2991-2995

[6] Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response? [J].

Jabbour, Elias ;

Kantarjian, Hagop M. ;

O'Brien, Susan ;

Shan, Jianqin ;

Quintas-Cardama, Alfonso ;

Garcia-Manero, Guillermo ;

Rios, Mary Beth ;

Cortes, Jorge E. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4260-4265

[7] Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia [J].

Karimata, Kaori ;

Masuko, Masayoshi ;

Ushiki, Takashi ;

Kozakai, Takashi ;

Shibasaki, Yasuhiko ;

Yano, Toshio ;

Abe, Takashi ;

Moriyama, Masato ;

Toba, Ken ;

Furukawa, Tatsuo ;

Aizawa, Yoshifusa .

INTERNAL MEDICINE, 2011, 50 (05) :481-485

[8] European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor [J].

Marin, David ;

Milojkovic, Dragana ;

Olavarria, Eduardo ;

Khorashad, Jamshid S. ;

de lavallade, Hugues ;

Reid, Alistair G. ;

Foroni, Letizia ;

Rezvani, Katayoun ;

Bua, Marco ;

Dazzi, Francesco ;

Pavlu, Jiri ;

Klammer, Matthias ;

Kaeda, Jaspal S. ;

Goldman, John M. ;

Apperley, Jane F. .

BLOOD, 2008, 112 (12) :4437-4444

[9] Chronic myeloid leukaemia as a model of disease evolution in human cancer [J].

Melo, Junia V. ;

Barnes, David J. .

NATURE REVIEWS CANCER, 2007, 7 (06) :441-453

[10] Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia [J].

Weisberg, Ellen ;

Manley, Paul W. ;

Cowan-Jacob, Sandra W. ;

Hochhaus, Andreas ;

Griffin, James D. .

NATURE REVIEWS CANCER, 2007, 7 (05) :345-U5

← 1 2 →